Ultragenyx, NephroGenex set IPO terms

Orphan drug company Ultragenyx Pharmaceutical Inc. (Novato, Calif.) and kidney disease company NephroGenex Inc. (Research Triangle Park, N.C.) set IPO terms late

Read the full 227 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE